Cargando…

Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals

INTRODUCTION: Central nervous system (CNS) penetration-effectiveness (CPE) rank was proposed in 2008 as an estimate of penetration of ARV regimen into the CNS, and validated as predictor of CSF HIV-1 replication. Results on predictive role of CPE on neurocognitive and clinical outcome were conflicti...

Descripción completa

Detalles Bibliográficos
Autores principales: Libertone, Raffaella, Lorenzini, Patrizia, Balestra, Pietro, Pinnetti, Carmela, Ricottini, Martina, Maddalena Plazzi, Maria, Menichetti, Samanta, Zaccarelli, Mauro, Nicastri, Emanuele, Bellagamba, Rita, Ammassari, Adriana, Antinori, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225401/
https://www.ncbi.nlm.nih.gov/pubmed/25394159
http://dx.doi.org/10.7448/IAS.17.4.19655
_version_ 1782343498622566400
author Libertone, Raffaella
Lorenzini, Patrizia
Balestra, Pietro
Pinnetti, Carmela
Ricottini, Martina
Maddalena Plazzi, Maria
Menichetti, Samanta
Zaccarelli, Mauro
Nicastri, Emanuele
Bellagamba, Rita
Ammassari, Adriana
Antinori, Andrea
author_facet Libertone, Raffaella
Lorenzini, Patrizia
Balestra, Pietro
Pinnetti, Carmela
Ricottini, Martina
Maddalena Plazzi, Maria
Menichetti, Samanta
Zaccarelli, Mauro
Nicastri, Emanuele
Bellagamba, Rita
Ammassari, Adriana
Antinori, Andrea
author_sort Libertone, Raffaella
collection PubMed
description INTRODUCTION: Central nervous system (CNS) penetration-effectiveness (CPE) rank was proposed in 2008 as an estimate of penetration of ARV regimen into the CNS, and validated as predictor of CSF HIV-1 replication. Results on predictive role of CPE on neurocognitive and clinical outcome were conflicting. MATERIALS AND METHODS: Retrospective, cross-sectional analysis of neurocognitive profile in HIV-infected cART-treated patients. All patients underwent neuropsychological (NP) assessment by standardized battery of 14 tests on 5 different domains. People were classified as having NCI if they scored >1 standard deviation (SD) below the normal mean in at least two tests, or >2 SD below in one test. Linear and logistic regression analyses were fitted using as outcome Npz8 and impaired/not impaired respectively. RESULTS: A total of 660 HIV-infected cART-treated individuals from 2009 to 2014, contributing a total of 1003 tests (mean age 49 (IQR 43–56), male 82%; median current CD4 586/mm(3); 18% HCV infected; HIV-RNA <40 cp/mL in 84%). Current ARV regimen was 2NRTIs+1NNRTI 50.3%, 2NRTI+1PI/r in 32.6%, NRTI sparing in 11.1%. Mean CPE of current regimens was 6.6 (95% CI 6.5–6.7). As per test multivariable analysis, higher CPE values were associated to poor NP tasks (Beta=−0,09; 95% CI −0,14 −0,03; p=0.002 at multivariable linear regression). The association between higher CPE and increased NCI risk was confirmed at multivariable logistic regression, with a 1.24-fold risk of NCI occurrence for each point increase of CPE of current regimen at the time of NP testing (see Table 1). In a sensitivity analysis performed only on patients at the first NP test, the association between higher CPE and poor NP tasks and enhanced NCI risk was only marginally confirmed (Beta=−0,05; [−0,12–0,02]; p=0,19; OR 1,13 [0,95–1,34]; p=0.17). Older age, longer time from HIV diagnosis, current CD4 count <350 cell/mm(3) and lower education level were all associated to an increased risk of NCI. CONCLUSIONS: In our analysis, higher CPE rank is associated to poorly performing at NP tasking. Even if selection bias could not be excluded due to retrospective cross-sectional design, these results fitted with the direct correlation between high CPE and HIV dementia recently recorded in a large observational database. We think that CPE use to guide ART in patients neurocognitively impaired should be revised.
format Online
Article
Text
id pubmed-4225401
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-42254012014-11-13 Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals Libertone, Raffaella Lorenzini, Patrizia Balestra, Pietro Pinnetti, Carmela Ricottini, Martina Maddalena Plazzi, Maria Menichetti, Samanta Zaccarelli, Mauro Nicastri, Emanuele Bellagamba, Rita Ammassari, Adriana Antinori, Andrea J Int AIDS Soc Poster Sessions – Abstract P123 INTRODUCTION: Central nervous system (CNS) penetration-effectiveness (CPE) rank was proposed in 2008 as an estimate of penetration of ARV regimen into the CNS, and validated as predictor of CSF HIV-1 replication. Results on predictive role of CPE on neurocognitive and clinical outcome were conflicting. MATERIALS AND METHODS: Retrospective, cross-sectional analysis of neurocognitive profile in HIV-infected cART-treated patients. All patients underwent neuropsychological (NP) assessment by standardized battery of 14 tests on 5 different domains. People were classified as having NCI if they scored >1 standard deviation (SD) below the normal mean in at least two tests, or >2 SD below in one test. Linear and logistic regression analyses were fitted using as outcome Npz8 and impaired/not impaired respectively. RESULTS: A total of 660 HIV-infected cART-treated individuals from 2009 to 2014, contributing a total of 1003 tests (mean age 49 (IQR 43–56), male 82%; median current CD4 586/mm(3); 18% HCV infected; HIV-RNA <40 cp/mL in 84%). Current ARV regimen was 2NRTIs+1NNRTI 50.3%, 2NRTI+1PI/r in 32.6%, NRTI sparing in 11.1%. Mean CPE of current regimens was 6.6 (95% CI 6.5–6.7). As per test multivariable analysis, higher CPE values were associated to poor NP tasks (Beta=−0,09; 95% CI −0,14 −0,03; p=0.002 at multivariable linear regression). The association between higher CPE and increased NCI risk was confirmed at multivariable logistic regression, with a 1.24-fold risk of NCI occurrence for each point increase of CPE of current regimen at the time of NP testing (see Table 1). In a sensitivity analysis performed only on patients at the first NP test, the association between higher CPE and poor NP tasks and enhanced NCI risk was only marginally confirmed (Beta=−0,05; [−0,12–0,02]; p=0,19; OR 1,13 [0,95–1,34]; p=0.17). Older age, longer time from HIV diagnosis, current CD4 count <350 cell/mm(3) and lower education level were all associated to an increased risk of NCI. CONCLUSIONS: In our analysis, higher CPE rank is associated to poorly performing at NP tasking. Even if selection bias could not be excluded due to retrospective cross-sectional design, these results fitted with the direct correlation between high CPE and HIV dementia recently recorded in a large observational database. We think that CPE use to guide ART in patients neurocognitively impaired should be revised. International AIDS Society 2014-11-02 /pmc/articles/PMC4225401/ /pubmed/25394159 http://dx.doi.org/10.7448/IAS.17.4.19655 Text en © 2014 Libertone R et al; licensee International AIDS Society http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Sessions – Abstract P123
Libertone, Raffaella
Lorenzini, Patrizia
Balestra, Pietro
Pinnetti, Carmela
Ricottini, Martina
Maddalena Plazzi, Maria
Menichetti, Samanta
Zaccarelli, Mauro
Nicastri, Emanuele
Bellagamba, Rita
Ammassari, Adriana
Antinori, Andrea
Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals
title Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals
title_full Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals
title_fullStr Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals
title_full_unstemmed Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals
title_short Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals
title_sort central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in hiv-infected individuals
topic Poster Sessions – Abstract P123
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225401/
https://www.ncbi.nlm.nih.gov/pubmed/25394159
http://dx.doi.org/10.7448/IAS.17.4.19655
work_keys_str_mv AT libertoneraffaella centralnervoussystempenetrationeffectivenessrankdoesnotreliablypredictneurocognitiveimpairmentinhivinfectedindividuals
AT lorenzinipatrizia centralnervoussystempenetrationeffectivenessrankdoesnotreliablypredictneurocognitiveimpairmentinhivinfectedindividuals
AT balestrapietro centralnervoussystempenetrationeffectivenessrankdoesnotreliablypredictneurocognitiveimpairmentinhivinfectedindividuals
AT pinnetticarmela centralnervoussystempenetrationeffectivenessrankdoesnotreliablypredictneurocognitiveimpairmentinhivinfectedindividuals
AT ricottinimartina centralnervoussystempenetrationeffectivenessrankdoesnotreliablypredictneurocognitiveimpairmentinhivinfectedindividuals
AT maddalenaplazzimaria centralnervoussystempenetrationeffectivenessrankdoesnotreliablypredictneurocognitiveimpairmentinhivinfectedindividuals
AT menichettisamanta centralnervoussystempenetrationeffectivenessrankdoesnotreliablypredictneurocognitiveimpairmentinhivinfectedindividuals
AT zaccarellimauro centralnervoussystempenetrationeffectivenessrankdoesnotreliablypredictneurocognitiveimpairmentinhivinfectedindividuals
AT nicastriemanuele centralnervoussystempenetrationeffectivenessrankdoesnotreliablypredictneurocognitiveimpairmentinhivinfectedindividuals
AT bellagambarita centralnervoussystempenetrationeffectivenessrankdoesnotreliablypredictneurocognitiveimpairmentinhivinfectedindividuals
AT ammassariadriana centralnervoussystempenetrationeffectivenessrankdoesnotreliablypredictneurocognitiveimpairmentinhivinfectedindividuals
AT antinoriandrea centralnervoussystempenetrationeffectivenessrankdoesnotreliablypredictneurocognitiveimpairmentinhivinfectedindividuals